Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-1278PMID 16585200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival.

  2005cited by this paper
• The survival kinases Akt and Pim as potential pharmacological targets.

  2005cited by this paper
• Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412.

  2005cited by this paper
• Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia.

  2005cited by this paper
• FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression.

  2005cited by this paper
• Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia

  2005cited by this paper
• Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo

  2005cited by this paper
• AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations.

  2005cited by this paper
• FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L).

  2005cited by this paper
• Restraining PI3K: mTOR signalling goes back to the membrane.

  2005cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005cited by this paper
• The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells

  2005cited by this paper
• PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

  2005cited by this paper
• Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival.

  2005cited by this paper
• Akt/Protein Kinase B Signaling Inhibitor-2, a Selective Small Molecule Inhibitor of Akt Signaling with Antitumor Activity in Cancer Cells Overexpressing Akt

  2004cited by this paper
• Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia.

  2004cited by this paper
• Prognostically useful gene-expression profiles in acute myeloid leukemia.

  2004cited by this paper
• The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins

  2004cited by this paper
• Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias

  2004cited by this paper
• Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak.

  2004cited by this paper
• FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins

  2004influential reference
• Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia.

  2003cited by this paper
• FLT3: ITDoes matter in leukemia

  2003cited by this paper
• Inhibition of Mitochondrial Respiration

  2003cited by this paper
• Survival of acute myeloid leukemia cells requires PI3 kinase activation.

  2003cited by this paper
• Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3‐kinase activation

  2003cited by this paper
• The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3.

  2003cited by this paper
• Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable

  2003cited by this paper
• A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo.

  2002cited by this paper
• CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).

  2002cited by this paper
• The roles of FLT3 in hematopoiesis and leukemia.

  2002cited by this paper
• Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

  2002cited by this paper
• Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.

  2001cited by this paper
• p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD

  2001influential reference
• Insulin-stimulated Protein Kinase B Phosphorylation on Ser-473 Is Independent of Its Activity and Occurs through a Staurosporine-insensitive Kinase*

  2001cited by this paper
• Akt and Bcl-xL Promote Growth Factor-independent Survival through Distinct Effects on Mitochondrial Physiology*

  2001cited by this paper
• Regulation of Protein Kinase B/Akt-Serine 473 Phosphorylation by Integrin-linked Kinase

  2001cited by this paper
• Flt 3 mutations from patients with acute myeloid leukemia induce transformation of 32 D cells mediated by the Ras and STAT 5 pathways

  2000cited by this paper
• Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines

  2000cited by this paper
• Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways.

  2000cited by this paper
• Cytochrome c Is Released from Mitochondria in a Reactive Oxygen Species (ROS)-dependent Fashion and Can Operate as a ROS Scavenger and as a Respiratory Substrate in Cerebellar Neurons Undergoing Excitotoxic Death*

  2000cited by this paper
• Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation

  2000cited by this paper
• Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1.

  1999cited by this paper
• Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

  1999cited by this paper
• Mechanisms and consequences of activation of protein kinase B/Akt.

  1998influential reference
• Granzyme Release and Caspase Activation in Activated Human T-Lymphocytes*

  1998cited by this paper
• R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways.

  1997cited by this paper
• Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate

  1997cited by this paper
• Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

  1997cited by this paper
• Transformation of hematopoietic cells by BCR/ABL requires activation of a PI‐3k/Akt‐dependent pathway

  1997cited by this paper
• The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.

  1995cited by this paper
• Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

  1995cited by this paper
• NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3).

  1991cited by this paper
• NB 4 , a Maturation Inducible Cell Line With t ( 15 ; 17 ) Marker Isolated From a Human Acute Promyelocytic Leukemia ( M 3 )

  year unknowncited by this paper

• Antihypertensive effects and mechanisms of wheat oligopeptides in spontaneously hypertensive rats

  2025cites this paper
• Dual-targeting CD33/CD123 NANOBODY T-cell engager with potent anti-AML activity and good safety profile

  2024cites this paper
• Circulating tumour cell clusters: isolation, biological significance and therapeutic implications

  2024cites this paper
• Nano-sensitizer with self-amplified drug release and hypoxia normalization properties potentiates efficient chemoradiotherapy of pancreatic cancer.

  2024cites this paper
• Network pharmacology and in vitro experiments reveal sophoridine‐induced apoptosis and G1 phase arrest via ROS‐dependent PI3K/Akt/FoxO3a pathway activation in human bladder cancer cells

  2024cites this paper
• Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.

  2023cites this paper
• Adult-type granulosa cell tumor of the ovary.

  2022cites this paper
• KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib via Inhibiting FOXO3a/GADD45α Pathway

  2022influential citation
• High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cells

  2021cites this paper
• CircRNA ANXA2 Promotes Lung Cancer Proliferation and Metastasis by Upregulating PDPK1 Expression

  2021cites this paper
• DNA damage induced by KP372-1 hyperactivates PARP1 and enhances lethality of pancreatic cancer cells with PARP inhibition

  2020cites this paper
• Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a

  2020cites this paper
• Kobe University Repository : Kernel タイトル Tit le A phase I study of single-agent BEZ 235 special delivery system sachet in Japanese pat ients with advanced solid tumors 著者

  2020cites this paper
• Applied electric fields suppress osimertinib-induced cytotoxicity via inhibiting FOXO3a nuclear translocation through AKT activation.

  2020cites this paper
• Multi-spectroscopic investigation, molecular docking and molecular dynamic simulation of competitive interactions between flavonoids (quercetin and rutin) and sorafenib for binding to human serum albumin.

  2020cites this paper
• Erhöhung der Sensitivität des klassischen Hodgkin Lymphoms auf epigenetische Therapie

  2019cites this paper
• LncRNA GAS6-AS2 facilitates tumor growth and metastasis of hepatocellular carcinoma by activating the PI3K/AKT/FoxO3a signaling pathway.

  2019cites this paper
• Current perspective on the regulation of FOXO4 and its role in disease progression

  2019cites this paper
• Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors.

  2019cites this paper
• Deciphering Cellular Signaling Pathways and their Perturbations in Disease Using Network-Based Strategies

  2018cites this paper
• 3 The PI 3 K / PKB Signaling Module in Normal and Malignant Hematopoiesis

  2018cites this paper
• Role of Apoptosis and Mitochondrial Dysfunction in the Treatment of Leukemia Types

  2018influential citation
• A phase I study of single-agent BEZ235 special delivery system sachet in Japanese patients with advanced solid tumors

  2018cites this paper
• Breast cancer suppression by aplysin is associated with inhibition of PI3K/AKT/FOXO3a pathway

  2017cites this paper
• The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia.

  2017cites this paper
• Cell-Specific Computational Modeling of the PIM Pathway in Acute Myeloid Leukemia.

  2017cites this paper
• Experimental evidences for miR-30b as a negative regulator of FOXO3 upregulated by kynurenine

  2017cites this paper
• Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.

  2016cites this paper
• Rational Combinations of mTOR Inhibitors as Anticancer Strategies

  2016cites this paper
• Phospho-Inositol-3-Kinase Activity and Dysregulation in Pediatric Leukemia and Lymphoma

  2016cites this paper
• Loss of Dnmt3b accelerates MLL-AF9 leukemia progression

  2016cites this paper
• MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells

  2016cites this paper
• Outlook on PI3K/AKT/mTOR inhibition in acute leukemia

  2015cites this paper
• Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: its potential use in the treatment of bladder cancers.

  2015cites this paper
• [MORPHOFUNCTIONAL STATE OF BLOOD CELLS AFTER CHRONIC EXPOSURE OF THE PROTEIN KINASES INHIBITOR MALEIMIDE DERIVATIVE].

  2015cites this paper
• Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway.

  2015cites this paper
• SoNar, a Highly Responsive NAD+/NADH Sensor, Allows High-Throughput Metabolic Screening of Anti-tumor Agents.

  2015cites this paper
• Down-regulation of superoxide dismutase 1 by PMA is involved in cell fate determination and mediated via protein kinase D2 in myeloid leukemia cells.

  2015cites this paper
• The PI3K-AKT-mTOR Signaling Network in AML

  2015cites this paper
• Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy

  2014cites this paper
• The PIM Family of Serine/Threonine Kinases in Cancer

  2014cites this paper
• FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells

  2014cites this paper
• Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis

  2014cites this paper
• FoxO3a and disease progression World Journal of Biological Chemistry

  2014cites this paper
• The PDK1 master kinase is over-expressed in acute myeloid leukemia and promotes PKC-mediated survival of leukemic blasts

  2014cites this paper
• FoxO3a and disease progression.

  2014cites this paper
• PI3K-AKT-mTOR-Signaling and beyond: the Complex Network in Gastroenteropancreatic Neuroendocrine Neoplasms

  2014cites this paper
• The role of FOXL2 in the pathogenesis of adult ovarian granulosa cell tumours.

  2014cites this paper
• Cooperativity of CD44 and CD49d in Leukemia Cell Homing, Migration, and Survival Offers a Means for Therapeutic Attack

  2013cites this paper
• Mechanisms of apoptosis induction by simultaneous inhibition of PI3K and FLT3-ITD in AML cells in the hypoxic bone marrow microenvironment.

  2013cites this paper
• Roles of PI3K/AKT/PTEN Pathway as a Target for Pharmaceutical Therapy

  2013cites this paper
• Pim kinases in cancer: diagnostic, prognostic and treatment opportunities.

  2013cites this paper
• Attack Survival Offers a Means for Therapeutic Leukemia Cell Homing , Migration , and Cooperativity of CD 44 and CD 49 d in

  2013cites this paper
• New Agents and Approaches for Targeting the RAS/RAF/MEK/ERK and PI3K/AKT/mTOR Cell Survival Pathways

  2013cites this paper
• Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia

  2013cites this paper
• PIF-pocket as a target for C. albicans Pkh selective inhibitors.

  2013cites this paper
• Selective Akt Inhibitors Synergize with Tyrosine Kinase Inhibitors and Effectively Override Stroma-Associated Cytoprotection of Mutant FLT3-Positive AML Cells

  2013cites this paper
• Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance

  2012cites this paper
• Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.

  2012cites this paper
• Forkhead Transcription Factor FOXO3a Protein Activates Nuclear Factor κB through B-cell lymphoma/leukemia 10 (BCL10) Protein and Promotes Tumor Cell Survival in Serum Deprivation*

  2012cites this paper
• The class I PI3K/Akt pathway is critical for cancer cell survival in dogs and offers an opportunity for therapeutic intervention

  2012cites this paper
• The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia.

  2012cites this paper
• PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes

  2012cites this paper
• Identification, in vitro activity and mode of action of phosphoinositide-dependent-1 kinase inhibitors as antifungal molecules.

  2011cites this paper
• Tumor suppressor FOXO3 mediates signals from the EGF receptor to regulate proliferation of colonic cells.

  2011cites this paper
• Akt, FoxO and regulation of apoptosis.

  2011cites this paper
• Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health

  2011cites this paper
• The physiology and pathology of inositide signaling in the nucleus

  2011cites this paper
• Physiology and pathology of nuclear phospholipase C β1.

  2011cites this paper
• Deciphering the role of forkhead transcription factors in cancer therapy.

  2011influential citation
• Kinase Inhibitors in Signal Transduction Therapy

  2011cites this paper
• Complex Systems Biology of Mammalian Cell Cycle Signaling in Cancer

  2011cites this paper
• The PI3K/PKB Signaling Module in Normal and Malignant Hematopoiesis

  2011cites this paper
• FMS-like tyrosine kinase 3 inhibitors: a patent review

  2011cites this paper
• Combining the FLT3 Inhibitor PKC412 and the Triterpenoid CDDO-Me Synergistically Induces Apoptosis in Acute Myeloid Leukemia with the Internal Tandem Duplication Mutation

  2010cites this paper
• Bench to bedside targeting of FLT3 in acute leukemia.

  2010cites this paper
• Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia

  2010cites this paper
• Drug resistance in mutant FLT3-positive AML

  2010cites this paper
• Hematological effects of protein kinases inhibitor maleimide derivative (1-(4 -Cl-benzyl)-3-Cl-4-(CF3-phenylamino)-1H-pyrrole-2,5-dione)

  2010cites this paper
• Hematological eff ects of protein kinases inhibitor maleimide derivative (1-(4 -Cl-benzyl)-3-Cl-4-(CF 3 -phenylamino)-1Н-pyrrole-2,5-dione)

  2010cites this paper
• Understanding FOXO, new views on old transcription factors.

  2010cites this paper
• A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer

  2009cites this paper
• Regulation of the Interaction between Protein Kinase C-related Protein Kinase 2 (PRK2) and Its Upstream Kinase, 3-Phosphoinositide-dependent Protein Kinase 1 (PDK1)*

  2009cites this paper
• Targeted small-molecule inhibitors of protein kinase B as anticancer agents.

  2009cites this paper
• Adding more content to screening: reactivation of FOXO as a therapeutic strategy

  2009cites this paper
• Down-Regulation of 3-Phosphoinositide–Dependent Protein Kinase-1 Levels Inhibits Migration and Experimental Metastasis of Human Breast Cancer Cells

  2009cites this paper
• Selective apoptosis induction by the cancer chemopreventive agent N-(4-hydroxyphenyl)retinamide is achieved by modulating mitochondrial bioenergetics in premalignant and malignant human prostate epithelial cells

  2009cites this paper
• Development of techological platforms for the identification of novel cellular modulators of FOXO activity

  2009cites this paper
• Efficacy of RNAi-induced down-regulation of wild-type FLT3 on NF-κB pathway in THP-1 cell line

  2008cites this paper
• Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemia

  2008cites this paper
• A Preliminary Assessment of the Structure-Activity Relationship of Benzimidazole-Based Anti-Proliferative Agents.

  2008cites this paper
• Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival

  2008cites this paper
• Akt pathway as a target for therapeutic intervention in HNSCC.

  2008cites this paper
• Novel 2‐step synthetic indole compound 1,1,3‐tri(3‐indolyl)cyclohexane inhibits cancer cell growth in lung cancer cells and xenograft models

  2008cites this paper
• Individualized molecular medicine: linking functional proteomics to select therapeutics targeting the PI3K pathway for specific patients.

  2008cites this paper
• Small molecules ATP-competitive inhibitors of FLT3: a chemical overview.

  2008cites this paper
• FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells

  2008cites this paper
• Regulation of 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) by Src Involves Tyrosine Phosphorylation of PDK1 and Src Homology 2 Domain Binding*

  2008cites this paper
• Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens

  2008cites this paper
• Is it important to decipher the heterogeneity of "normal karyotype AML"?

  2008cites this paper